Publications by authors named "Cedrick Wallet"

Claim this Profile
E
Effect of HIV infection and antiretroviral therapy initiation on genome-wide DNA methylation patterns.
Andrés Esteban-Cantos, Javier Rodríguez-Centeno, Juan C Silla, Pilar Barruz, Fátima Sánchez-Cabo, Cédrick Wallet

EBioMedicine· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).
Alexandre Duvignaud, Edouard Lhomme, Racha Onaisi, Rémi Sitta, Ambre Gelley, Cédrick Wallet

Clin Microbiol Infect· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial.
Antoine Italiano, Derek Dinart, Isabelle Soubeyran, Carine Bellera, Hélène Espérou, Cédrick Wallet

BMC Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial.
Andrés Esteban-Cantos, Javier Rodríguez-Centeno, Pilar Barruz, Belén Alejos, Gabriel Saiz-Medrano, Cédrick Wallet

Lancet HIV· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individuals.
Mathieu Chalouni, Javier Rodriguez-Centeno, Assia Samri, Julian Blanco, Natalia Stella-Ascariz, Cedrick Wallet

PLoS One· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial.
Jose I Bernardino, Amanda Mocroft, Cedrick Wallet, Stéphane de Wit, Christine Katlama

PLoS One· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial.
Adriana Ammassari, Wolfgang Stöhr, Andrea Antinori, Jean-Michel Molina, Christine Schwimmer, Cedrick Wallet

J Acquir Immune Defic Syndr· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1.
Natalia Stella-Ascariz, Rocio Montejano, Javier Rodriguez-Centeno, Belen Alejos, Christine Schwimmer, Cédrick Wallet

J Infect Dis· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial.
Jose I Bernardino, Amanda Mocroft, Patrick W Mallon, Cedrick Wallet, Jan Gerstoft

Lancet HIV· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.
François Raffi, Abdel G Babiker, Laura Richert, Jean-Michel Molina, Elizabeth C George, Cédrick Wallet

Lancet· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis